TL;DR: Online courses from Stanford University are available to take for free on edX.

One person that helped bring the chill was an analyst cutting his price target. Another two were executives at the biotech selling chunks of stock. The company was the target of an analyst price ...

We recently published 10 Stocks Crash as AI Glow Fades. Recursion Pharmaceuticals, Inc. (NASDAQ:RXRX) is one of Wednesday’s worst performers. Recursion Pharmaceuticals dropped for a third straight day ...

The Florida Python Challenge is arguably the most well-known and well-attended snake hunt in the country. And according to the results released Wednesday, the 2025 Challenge that took place in July ...

Taylor Stanberry, a Naples native, won the 2025 Florida Python Challenge, removing 60 Burmese pythons. The annual competition aims to control the invasive python population in Florida. This is the ...

Taylor Stanberry won the 2025 Florida Python Challenge, removing 60 invasive Burmese pythons. The first-time participant earned $10,000 for her efforts during the 10-day competition. Stanberry, along ...

The company isn't the only developer of a drug for FAP, a rare genetic disease. A rival just reported that its own FAP treatment is advancing to late-stage testing. 10 stocks we like better than ...

REC-3565, a MALT1 inhibitor developed via AI, is now in Phase 1 for blood cancers. REC-617 showed encouraging signs in a patient with recurrent ovarian cancer. Get the data-driven signals to profit ...

Shares of Recursion Pharmaceuticals climbed after the company said it has agreed to purchase Rallybio's interest in a drug-development plan that aims to treat a rare genetic bone disease. The stock ...

A team led by Regina Barzilay, a computer science professor at the Massachusetts Institute of Technology, has launched Boltz-2, an algorithm that unites protein folding and prediction of ...